The Fremont company sold extra shares at the top of its proposed range, and the stock jumped more than 30% in initial trading ...

In a notification the state received from Replimune on Monday, the Woburn-based company said it was laying off 63 employees, ...

The biotech will primarily focus on taking the oral and injectable form of its lead candidate, ribupatide, through late-stage obesity trials.

China’s biotech rise has been a persistent concern for federal health leaders, Congress, and many biopharma executives. | ...

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to ...

When Kailera revealed its plans for an IPO last month, there was a feeling that it could be huge – and that expectation has ...

Revolution Medicines announced a stunning survival benefit for its experimental drug in a Phase 3 pancreatic cancer study ...

New research questions GLP-1's purpose, a pancreatic cancer breakthrough, and more biotech news from The Readout ...

Alamar Biosciences employees, family and friends attend a Nasdaq bell-ringing ceremony. "There are so many diseases we can ...

The state cabinet Thursday has approved a centre of excellence for AI in biotechnology at the Institute of Bioinformatics and ...

MastCURe, a high-profile research consortium, has been awarded €1.3M in funding from the Eureka Eurostars program. The ...

The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to ...